The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
The HIV-1 Protease as a Therapeutic Target for AIDS
Abstract
HIV produces a small , dimeric aspartyl protease which specifically cleaves the polyprotein precursors encoding the structural proteins and enzymes of the virus. This proteolytic activity is absolutely required for the production of mature, infectious virions and is therefore an attractive target for therapeutic intervention. This review summarizes the strategies and multidisciplinary efforts that have been applied to date to the identification of specific inhibitors of this critical viral enzyme. These inhibitors include rationally designed peptide substrate analogs, compounds conceived from tertiary structure information on the enzyme and natural products. Future directions in the discovery and development of HIV-1 protease inhibitors are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,578
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
Larder, B. A., Darby, G., & Richman, D. D. (1989) · Science · doi:10.1126/science.2467383 · Cited by 1,559
Active human immunodeficiency virus protease is required for viral infectivity
Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., & Sigal, I. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4686 · Cited by 1,307
Nucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 Protease
Wlodawer, A., Miller, M., Jaskólski, M., Sathyanarayana, B. K., Baldwin, E., Weber, I. T., Selk, L. M., Clawson, L., Schneider, J., & Kent, S. B. H. (1989) · Science · doi:10.1126/science.2548279 · Cited by 1,168
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression
Jacks, T., Power, M. D., Masiarz, F. R., Luciw, P. A., Barr, P. J., & Varmus, H. E. (1988) · Nature · doi:10.1038/331280a0 · Cited by 966
Rational Design of Peptide-Based HIV Proteinase Inhibitors
Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Kröhn, A., et al. (1990) · Science · doi:10.1126/science.2183354 · Cited by 929
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
Navia, M. A., Fitzgerald, P. M. D., McKeever, B. M., Leu, C.-T., Heimbach, J. C., Herber, W. K., Sigal, I. S., Darke, P. L., & Springer, J. P. (1989) · Nature · doi:10.1038/337615a0 · Cited by 894
Gheysen, D., Jacobs, E., de Foresta, F., Thiriart, C., Francotte, M., Thines, D., & De Wilde, M. (1989) · Cell · doi:10.1016/0092-8674(89)90873-8 · Cited by 747
Nucleotide Sequence and Expression of an AIDS-Associated Retrovirus (ARV-2)
Sanchez-Pescador, R., Power, M. D., Barr, P. J., Steimer, K. S., Stempien, M. M., Brown-Shimer, S. L., Gee, W. W., Renard, A., Randolph, A., Levy, J. A., et al. (1985) · Science · doi:10.1126/science.2578227 · Cited by 719
Miller, M., Schneider, J., Sathyanarayana, B. K., Toth, M. V., Marshall, G. R., Clawson, L., Selk, L., Kent, S. B. H., & Wlodawer, A. (1989) · Science · doi:10.1126/science.2686029 · Cited by 684
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus
Muesing, M. A., Smith, D. H., Cabradilla, C. D., Benton, C. V., Lasky, L. A., & Capon, D. J. (1985) · Nature · doi:10.1038/313450a0 · Cited by 682
The Structure and Function of the Aspartic Proteinases
Davies, D. R. (1990) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.19.060190.001201 · Cited by 658
A structural model for the retroviral proteases
Pearl, L. H., & Taylor, W. R. (1987) · Nature · doi:10.1038/329351a0 · Cited by 598
Novel Fluorogenic Substrates for Assaying Retroviral Proteases by Resonance Energy Transfer
Matayoshi, E. D., Wang, G. T., Krafft, G. A., & Erickson, J. (1990) · Science · doi:10.1126/science.2106161 · Cited by 592
Erickson, J., Neidhart, D. J., VanDrie, J., Kempf, D. J., Wang, X. C., Norbeck, D. W., Plattner, J. J., Rittenhouse, J. W., Turon, M., Wideburg, N., et al. (1990) · Science · doi:10.1126/science.2200122 · Cited by 527
The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis
Omura, S. (1976) · Bacteriological Reviews · doi:10.1128/br.40.3.681-697.1976 · Cited by 493
Lapatto, R., Blundell, T., Hemmings, A., Overington, J., Wilderspin, A., Wood, S., Merson, J. R., Whittle, P. J., Danley, D. E., Geoghegan, K. F., et al. (1989) · Nature · doi:10.1038/342299a0 · Cited by 456
TRANSITION STATE ANALOG INHIBITORS AND ENZYME CATALYSIS
Wolfenden, R. (1976) · Annual Review of Biophysics and Bioengineering · doi:10.1146/annurev.bb.05.060176.001415 · Cited by 416
A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle Maturation
McQuade, T. J., Tomasselli, A. G., Liu, L., Karacostas, V., Moss, B., Sawyer, T. K., Heinrikson, R. L., & Tarpley, W. G. (1990) · Science · doi:10.1126/science.2405486 · Cited by 374
Peng, C., Ho, B. K., Chang, T. W., & Chang, N. T. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2550-2556.1989 · Cited by 371
Fluoro ketone inhibitors of hydrolytic enzymes
Gelb, M. H., Svaren, J. P., & Abeles, R. H. (1985) · Biochemistry · doi:10.1021/bi00329a001 · Cited by 343
Standardized and simplified nomenclature for proteins common to all retroviruses
Leis, J., Baltimore, D., Bishop, J. M., Coffin, J., Fleissner, E., Goff, S. P., Oroszlan, S., Robinson, H., Skalka, A. M., & Temin, H. M. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1808-1809.1988 · Cited by 331
Interferon-α But Not AZT Suppresses HIV Expression in Chronically Infected Cell Lines
Poli, G., Orenstein, J. M., Kinter, A., Folks, T. M., & Fauci, A. S. (1989) · Science · doi:10.1126/science.2470148 · Cited by 328
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Seelmeier, S., Schmidt, H., Turk, V, & von der Helm, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6612 · Cited by 328
Complete mutagenesis of the HIV-1 protease
Loeb, D. D., Swanstrom, R., Everitt, L., Manchester, M., Stamper, S. E., & Hutchison, C. A. (1989) · Nature · doi:10.1038/340397a0 · Cited by 327
Debouck, C., Gorniak, J. G., Strickler, J. E., Meek, T. D., Metcalf, B. W., & Rosenberg, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8903 · Cited by 278
Self-citationRates and dates of divergence between AIDS virus nucleotide sequences.
(1988) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040503 · Cited by 278
Swain, A. L., Miller, M. M., Green, J., Rich, D. H., Schneider, J., Kent, S. B., & Wlodawer, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8805 · Cited by 275
Darke, P. L., Nutt, R. F., Brady, S. F., Garsky, V. M., Ciccarone, T. M., Leu, C.-T., Lumma, P. K., Freidinger, R. M., Veber, D. F., & Sigal, I. S. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80839-8 · Cited by 268
DesJarlais, R. L., Seibel, G. L., Kuntz, I. D., Furth, P. S., Alvarez, J. C., Ortiz de Montellano, P. R., DeCamp, D. L., Babé, L. M., & Craik, C. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6644 · Cited by 253
Greenlee, W. J. (1990) · Medicinal Research Reviews · doi:10.1002/med.2610100203 · Cited by 248
Hyland, L. J., Tomaszek, T. A., & Meek, T. D. (1991) · Biochemistry · doi:10.1021/bi00098a024 · Cited by 238
Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease
Schneider, J., & Kent, S. B. H. (1988) · Cell · doi:10.1016/0092-8674(88)90199-7 · Cited by 236
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues
Meek, T. D., Lambert, D. M., Dreyer, G. B., Carr, T. J., Tomaszek, T. A., Moore, M. L., Strickler, J. E., Debouck, C., Hyland, L. J., Matthews, T. J., et al. (1990) · Nature · doi:10.1038/343090a0 · Cited by 229
Self-citationJaskolski, M., Tomasselli, A. G., Sawyer, T. K., Staples, D. G., Heinrikson, R. L., Schneider, J., Kent, S. B. H., & Wlodawer, A. (1991) · Biochemistry · doi:10.1021/bi00220a023 · Cited by 227
Retroviral protease-like sequence in the yeast transposon Ty 1
TOH, H., ONO, M., SAIGO, K., & MIYATA, T. (1985) · Nature · doi:10.1038/315691a0 · Cited by 218
Expression and Processing of the AIDS Virus Reverse Transcriptase in Escherichia coli
Farmerie, W. G., Loeb, D. D., Casavant, N. C., Hutchison, C. A., Edgell, M. H., & Swanstrom, R. (1987) · Science · doi:10.1126/science.2436298 · Cited by 203
Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides
Dutia, B. M., Frame, M. C., Subak-Sharpe, J. H., Clark, W. N., & Marsden, H. S. (1986) · Nature · doi:10.1038/321439a0 · Cited by 202
Dreyer, G. B., Metcalf, B. W., Tomaszek, T. A., Carr, T. J., Chandler, A. C., Hyland, L., Fakhoury, S. A., Magaard, V. W., Moore, M. L., & Strickler, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9752 · Cited by 201
Sensitive, soluble chromogenic substrates for HIV-1 proteinase.
Richards, A. D., Phylip, L. H., Farmerie, W. G., Scarborough, P. E., Alvarez, A., Dunn, B. M., Hirel, P. H., Konvalinka, J., Strop, P., & Pavlickova, L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38989-6 · Cited by 198
A simple, continuous fluorometric assay for HIV protease
TOTH, M. V., & MARSHALL, G. R. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00994.x · Cited by 197
Ashorn, P., McQuade, T. J., Thaisrivongs, S., Tomasselli, A. G., Tarpley, W. G., & Moss, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7472 · Cited by 186
Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne)
Henderson, L. E., Benveniste, R. E., Sowder, R., Copeland, T. D., Schultz, A. M., & Oroszlan, S. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.2587-2595.1988 · Cited by 185
Human immunodeficiency virus protease
Darke, P. L., Leu, C. T., Davis, L. J., Heimbach, J. C., Diehl, R. E., Hill, W. S., Dixon, R. A., & Sigal, I. S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94177-3 · Cited by 174
Meek, T. D., Dayton, B. D., Metcalf, B. W., Dreyer, G. B., Strickler, J. E., Gorniak, J. G., Rosenberg, M., Moore, M. L., Magaard, V. W., & Debouck, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.6.1841 · Cited by 174
Self-citationCohen, E. A., Gaudreau, P., Brazeau, P., & Langelier, Y. (1986) · Nature · doi:10.1038/321441a0 · Cited by 173
Molecular Modeling of the HIV-1 Protease and Its Substrate Binding Site
Weber, I. T., Miller, M., Jaskólski, M., Leis, J., Skalka, A. M., & Wlodawer, A. (1989) · Science · doi:10.1126/science.2537531 · Cited by 170
Effective blocking of HIV‐1 proteinase activity by characteristic inhibitors of aspartic proteinases
Richards, A. D., Roberts, R., Dunn, B. M., Graves, M. C., & Kay, J. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81251-7 · Cited by 166
Kräusslich, H. G., Ingraham, R. H., Skoog, M. T., Wimmer, E., Pallai, P. V., & Carter, C. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.807 · Cited by 166
Proteolytic processing of polyproteins in the replication of RNA viruses
Hellen, C. U. T., Kraeusslich, H. G., & Wimmer, E. (1989) · Biochemistry · doi:10.1021/bi00452a001 · Cited by 164
Peptide substrates and inhibitors of the HIV-1 protease
Moore, M. L., Bryan, W. M., Fakhoury, S. A., Magaard, V. W., Huffman, W. F., Dayton, B. D., Meek, T. D., Hyland, L., Dreyer, G. B., Metcalf, B. W., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90008-9 · Cited by 161
Self-citationZhang, Z., Poorman, R. A., Maggiora, L. L., Heinrikson, R. L., & Kézdy, F. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98445-0 · Cited by 150
Pettit, S. C., Simsic, J., Loeb, D. D., Everitt, L., Hutchison, C. A., & Swanstrom, R. I. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98720-x · Cited by 142
Rich, D. H., Green, J., Toth, M. V., Marshall, G. R., & Kent, S. B. H. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00167a003 · Cited by 142
Loeb, D. D., Hutchison, C. A., Edgell, M. H., Farmerie, W. G., & Swanstrom, R. I. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.111-121.1989 · Cited by 139
Substrate analog inhibition and active site titration of purified recombinant HIV-1 protease
Tomasselli, A. G., Olsen, M. K., Hui, J. O., Staples, D. J., Sawyer, T. K., Heinrikson, R. L., & Tomich, C.-S. C. (1990) · Biochemistry · doi:10.1021/bi00453a036 · Cited by 127
Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease.
Billich, S., Knoop, M.-T., Hansen, J., Strop, P., Sedláček, J., Mertz, R., & Moelling, K. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81300-5 · Cited by 126
Rich, D. H., Sun, C. Q., Prasad, J. V. N. V., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00107a049 · Cited by 126
L-687,908, a potent hydroxyethylene containing HIV protease inhibitor
Vacca, J. P., Guare, J. P., DeSolms, S. J., Sanders, W. M., Giuliani, E. A., Young, S. D., Darke, P. L., Sigal, I. S., & Schleif, W. A. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00107a050 · Cited by 124
Cheng, Y.-S. E., Yin, F. H., Foundling, S. I., Blomstrom, D. C., & Kettner, C. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9660 · Cited by 121
Viral proteinases: weakness in strength
Kay, J., & Dunn, B. M. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90015-t · Cited by 118
Structural and evolutionary relationships between retroviral and eukaryotic aspartic proteinases
Rao, J., Erickson, J. W., & Wlodawer, A. (1991) · Biochemistry · doi:10.1021/bi00233a005 · Cited by 105
Weber, I. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86974-5 · Cited by 104
Mizrahi, V., Lazarus, G. M., Miles, L. M., Meyers, C. A., & Debouck, C. M. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90493-1 · Cited by 90
Self-citationGeneration and characterization of the human immunodeficiency virus type 1 mutants
Adachi, A., Ono, N., Sakai, H., Ogawa, K., Shibata, R., Kiyomasu, T., Masuike, H., & Ueda, S. (1991) · Archives of Virology · doi:10.1007/bf01310491 · Cited by 89
Human immunodeficiency virus protease: A target for aids therapy
Debouck, C. M., & Metcalf, B. W. (1990) · Drug Development Research · doi:10.1002/ddr.430210102 · Cited by 81
Self-citationGenetic locus, primary structure, and chemical synthesis of human immunodeficiency virys protease
Copeland, T. D., & Oroszlan, S. I. (1988) · Gene Analysis Techniques · doi:10.1016/0735-0651(88)90010-6 · Cited by 80
Structure and Function of Retroviral Proteases
Fitzgerald, P. M. D., & Springer, J. P. (1991) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.20.060191.001503 · Cited by 76
Lillehoj, E. P., Salazar, F. H., Mervis, R. J., Raum, M. G., Chan, H. W., Ahmad, N., & Venkatesan, S. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.3053-3058.1988 · Cited by 73
Zinc inhibition of renin and the protease from human immunodeficiency virus type 1
Zhang, Z. Y., Reardon, I. M., Hui, J. O., O'Connell, K. L., Poorman, R. A., Tomasselli, A. G., & Heinrikson, R. L. (1991) · Biochemistry · doi:10.1021/bi00100a001 · Cited by 69
DiIanni, C. L., Davis, L. J., Holloway, M. K., Herber, W. K., Darke, P. L., Kohl, N. E., & Dixon, R. A. F. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44909-x · Cited by 68
Pal, R., Gallo, R. C., & Sarngadharan, M. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9283 · Cited by 68
Design and synthesis of new fluorogenic HIV protease substrates based on resonance energy transfer
Wang, G. T., Matayoshi, E. D., Huffaker, H. J., & Krafft, G. A. (1990) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)97099-0 · Cited by 65
Roberts, M., & Oroszlan, S. (1989) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/0006-291x(89)92459-5 · Cited by 65
McClements, W. L., Yamanaka, G. A., Garsky, V. M., Perry, H. C., Bacchetti, S., Colonno, R. J., & Stein, R. B. (1988) · Virology · doi:10.1016/0042-6822(88)90421-7 · Cited by 65
HIV-1 reproduction is inhibited by peptides derived from the N- and C-termini of HIV-1 protease
Schramm, H. J., Nakashima, H., Schramm, W., Wakayama, H., & Yamamoto, N. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91895-j · Cited by 64
Cheng, Y. E., McGowan, M. H., Kettner, C. A., Schloss, J. V., Erickson‐Viitanen, S., & Yin, F. H. (1990) · Gene · doi:10.1016/0378-1119(90)90308-e · Cited by 59
Affinity purification of the HIV-1 protease
Heimbach, J. C., Garsky, V. M., Michelson, S. R., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91762-2 · Cited by 58
Baum, E. Z., Bebernitz, G. A., & Gluzman, Y. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5573 · Cited by 52
Graves, M. C., Meidel, M. C., Pan, Y. E., Manneberg, M., Lahm, H., & Grüninger-Leitch, F. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91670-n · Cited by 52
Sub‐site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV‐1
Konvalinka, J., Štrop, P., Velek, J., Černá, V., Kostka, V., Phylip, L. H., Richards, A. D., Dunn, B. M., & Kay, J. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80966-m · Cited by 49
Grant, S. K., Deckman, I. C., Minnich, M. D., Culp, J. S., Franklin, S., Dreyer, G. B., Tomaszek, T. A., Debouck, C. M., & Meek, T. D. (1991) · Biochemistry · doi:10.1021/bi00098a021 · Cited by 46
Self-citationSynthetic non-peptide inhibitors of HIV protease
Blumenstein, J. J., Copeland, T. D., Oroszlan, S. I., & Michejda, C. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92318-8 · Cited by 38
Substitutions at the P2′ site of gag p17–p24 affect cleavage efficiency by HIV-1 protease
Margolin, N., Heath, W., Osborne, E., Lai, M., & Vlahos, C. J. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92060-d · Cited by 36
Inhibition of the aspartic proteinase from HIV‐2
Richards, A. D., Broadhurst, A. V., Ritchie, A. J., Dunn, B. M., & Kay, J. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80961-5 · Cited by 28
In vitro inhibition of HIV‐1 proteinase by cerulenin
Moelling, K., Schulze, T., Knoop, M.-T., Kay, J., Jupp, R. A., Nicolaou, G., & Pearl, L. H. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80595-a · Cited by 27
Craig, J. C., Grief, C., MILLS, J. S., Hockley, D. J., Duncan, I. B. R., & Roberts, N. A. (1991) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029100200308 · Cited by 26
Wondrak, E. M., Louis, J. M., Mora, P. T., & Oroszlan, S. I. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80328-z · Cited by 20
Cited by
Structure-Based Strategies for Drug Design and Discovery
Kuntz, I. D. (1992) · Science · doi:10.1126/science.257.5073.1078 · Cited by 989
Flexner, C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381808 · Cited by 852
Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors
Lam, P. Y. S., Jadhav, P. K., Eyermann, C. J., Hodge, C. N., Ru, Y., Bacheler, L. T., Meek, J. L., Otto, M. J., Rayner, M. M., Wong, Y. N., et al. (1994) · Science · doi:10.1126/science.8278812 · Cited by 834
Danner, S. A., Carr, A., Leonard, J. M., Lehman, L. M., Gudiol, F., Gonzales, J., Raventos, A., Rubio, R., Bouza, E., Pintado, V., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332303 · Cited by 567
Lopinavir/Ritonavir: A Review of its Use in the Management of HIV Infection
Cvetkovic, R. S., & Goa, K. L. (2003) · Drugs · doi:10.2165/00003495-200363080-00004 · Cited by 436
Metadata
- Authors
- DEBOUCK, C.
- Venue
- AIDS Research and Human Retroviruses
- Publisher
- SAGE Publications
- Published
- 1992-02
- Volume
- 8
- Issue
- 2
- Pages
- 153-164
- ISSN
- 0889-2229 (ISSN-L)
- 1931-8405
- OpenAlex
- W2069146496
- Cited by
- 341
- References
- 90
- FWCI
- 29.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.